Neo-adjuvant doxorubicin and cyclophosphamide followed by paclitaxel in triple-negative breast cancer among BRCA1 mutation carriers and non-carriers von Paluch-Shimon, Shani, Friedman, Eitan, Berger, Raanan, Papa, Moshe, Dadiani, Maya, Friedman, Neil, Shabtai, Moshe, Zippel, Dov, Gutman, Mordechai, Golan, Talia, Yosepovich, Ady, Catane, Raphael, Modiano, Tami, Kaufman, Bella

Volltext

Evaluation of tolerability and efficacy of incorporating carboplatin in neoadjuvant anthracycline and taxane based therapy in a BRCA1 enriched triple-negative breast cancer cohort von Sella, Tal, Gal Yam, Einav Nili, Levanon, Keren, Rotenberg, Tal Shapira, Gadot, Moran, Kuchuk, Iryna, Molho, Rinat Bernstein, Itai, Amit, Modiano, Tami Mekel, Gold, Raya, Kaufman, Bella, Shimon, Shani Paluch

Volltext

Does pathologic complete response predict for outcome in BRCA mutation carriers with triple-negative breast cancer? von Paluch-Shimon, Shani, Friedman, Eitan, Berger, Raanan, Papa, Moshe Zvi, Dadiani, Maya, Friedman, Neil, Shabtai, Moshe, Zippel, Douglas, Gutman, Mordechai, Golan, Talia, Catane, Raphael, Yosepovich, Ady, Mekel Modiano, Tami, Kaufman, Bella

Volltext

Hormone receptor expression is associated with a unique pattern of metastatic spread and increased survival among HER2-overexpressing breast cancer patients von Paluch-Shimon, Shani, Ben-Baruch, Noa, Wolf, Ido, Zach, Lior, Kopolovic, Juri, Kruglikova, Anna, Modiano, Tami, Yosepovich, Ady, Catane, Raphael, Kaufman, Bella

Volltext

High efficacy of pre-operative trastuzumab combined with paclitaxel following doxorubicin & cyclophosphamide in operable breast cancer von Paluch-Shimon, Shani, Wolf, Ido, Goldberg, Hadassah, Evron, Ella, Papa, Moshe Z., Shabtai, Moshe, Barsuk, Daphna, Yosepovich, Ady, Modiano, Tami, Catane, Raphael, Kaufman, Bella

Volltext